Teacher Retirement System of Texas
MLTX icon

Teacher Retirement System of Texas’s MoonLake Immunotherapeutics MLTX Stock Holding History

Teacher Retirement System of Texas’s Portfolio MLTX Stock Details MLTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,971
Closed -$282K – 2072
2025
Q2 		$282K Buy
5,971
+31
+0.5% +$1.26K ﹤0.01% 1788
2025
Q1 		$232K Sell
5,940
-592
-9% -$25.5K ﹤0.01% 1843
2024
Q4 		$354K Buy
6,532
+1,013
+18% +$51.7K ﹤0.01% 1350
2024
Q3 		$278K Buy
+5,519
New +$259K ﹤0.01% 1354
2024
Q2 		– Sell
-4,002
Closed -$201K – 1651
2024
Q1 		$201K Sell
4,002
-147
-4% -$7.97K ﹤0.01% 1585
2023
Q4 		$251K Sell
4,149
-991
-19% -$51.1K ﹤0.01% 1611
2023
Q3 		$293K Buy
+5,140
New +$284K ﹤0.01% 1604

Other funds holding MLTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Teacher Retirement System of Texas's MLTX Position: Q3 2025 in Review

Teacher Retirement System of Texas sold out of MoonLake Immunotherapeutics (MLTX) in Q3 2025, closing a stake of 5,971 shares — an estimated $282K sold.

Teacher Retirement System of Texas first reported a position in MLTX in Q3 2023 and held it in 7 quarters. The position peaked at $354K in Q4 2024. 134 funds tracked by Wall St. Rank hold MLTX as of Q3 2025.

  • Teacher Retirement System of Texas reported no remaining MoonLake Immunotherapeutics position as of Q3 2025 after selling out during the quarter.
  • Teacher Retirement System of Texas sold 5,971 MoonLake Immunotherapeutics shares in Q3 2025, an estimated $282K.
  • Teacher Retirement System of Texas first reported a position in MoonLake Immunotherapeutics in Q3 2023 and held it in 7 quarters.
  • Teacher Retirement System of Texas's MoonLake Immunotherapeutics position peaked at $354K in Q4 2024.
  • 134 funds tracked by Wall St. Rank held MoonLake Immunotherapeutics as of Q3 2025.

Based on Teacher Retirement System of Texas's 13F filing for Q3 2025, filed 30 Oct 2025.